Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles

Abstract This study evaluated anti-Müllerian hormone (AMH) as a possible predictor of twin pregnancy in women undergoing fresh cycles who had more than one embryo transferred. A retrospective study was performed of 139 patients undergoing fresh non-donor cycles which resulted in either singleton or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Reproductive biomedicine online 2013-04, Vol.26 (4), p.360-367
Hauptverfasser: Tal, Reshef, Seifer, David B, Khanimov, Moisey, Schwartz, Eliana, Grazi, Richard V, Malter, Henry E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 367
container_issue 4
container_start_page 360
container_title Reproductive biomedicine online
container_volume 26
creator Tal, Reshef
Seifer, David B
Khanimov, Moisey
Schwartz, Eliana
Grazi, Richard V
Malter, Henry E
description Abstract This study evaluated anti-Müllerian hormone (AMH) as a possible predictor of twin pregnancy in women undergoing fresh cycles who had more than one embryo transferred. A retrospective study was performed of 139 patients undergoing fresh non-donor cycles which resulted in either singleton or twin pregnancy between 2009 and 2010 in this fertility clinic. Random serum AMH and other clinically relevant variables were compared. For further analysis, the population was stratified by age (
doi_str_mv 10.1016/j.rbmo.2012.12.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1324390191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1472648312007456</els_id><sourcerecordid>1324390191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-d1b4153db180a67776bca01d5fd7aa727bd0ee78a24f4a4132ced9c2cfcdebb93</originalsourceid><addsrcrecordid>eNp9kc-KFDEQxoMo7h99AQ-So5ceU0m6Mw0iLIuuwooH9RzSSfVuxnQyJt0r827efDHTzLoHD0KRVOD7fVS-IuQFsA0w6F7vNnmY0oYz4JtajPFH5BSk4k0ne3j80G_FCTkrZccYbNlWPCUnXEjoVS9OyXgRZ998-v0rBMzeRHqb8pQiUlNoffnocI_1iDPdZ3TezinTNNL5p4_0DnNZCi0-3gScU1wlN9FEe6ggHTOWW2oPNmB5Rp6MJhR8fn-fk2_v3329_NBcf776eHlx3VjZtnPjYJDQCjfUQU2nlOoGaxi4dnTKGMXV4Bii2houR2kkCG7R9Zbb0Tochl6ck1dH331OPxYss558sRiCiZiWoishRc-ghyrlR6nNqZSMo95nP5l80MD0mq_e6TVfveara9V8K_Ty3n8ZJnQPyN9Aq-DNUYD1l3cesy7WY6xj-ox21i75__u__Qe3wUdvTfiOByy7tORY89OgSwX0l3XD64KBM6Zk24k_LYaj_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1324390191</pqid></control><display><type>article</type><title>Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tal, Reshef ; Seifer, David B ; Khanimov, Moisey ; Schwartz, Eliana ; Grazi, Richard V ; Malter, Henry E</creator><creatorcontrib>Tal, Reshef ; Seifer, David B ; Khanimov, Moisey ; Schwartz, Eliana ; Grazi, Richard V ; Malter, Henry E</creatorcontrib><description>Abstract This study evaluated anti-Müllerian hormone (AMH) as a possible predictor of twin pregnancy in women undergoing fresh cycles who had more than one embryo transferred. A retrospective study was performed of 139 patients undergoing fresh non-donor cycles which resulted in either singleton or twin pregnancy between 2009 and 2010 in this fertility clinic. Random serum AMH and other clinically relevant variables were compared. For further analysis, the population was stratified by age (&lt;34 and ⩾34 years). Random serum AMH concentrations were 1.4-times greater in women conceiving twins compared with singletons ( P = 0.03). In women aged ⩾34, the AMH concentration in twins was 1.8-fold greater than singletons ( P = 0.001). Multivariate analysis demonstrated that AMH was an independent predictor of twins. ROC curve analysis showed that AMH had a significant predictive ability for twin pregnancy in women aged ⩾34 (AUC 0.67, P = 0.01). In contrast, in women aged &lt;34, AMH was not different between twin and singleton pregnancies. In summary, random serum AMH is an independent predictor of twin gestation when more than one embryo is transferred in women aged ⩾34. Considering a woman’s AMH before transferring more than one embryo may assist in reducing the incidence of twins. Transferring multiple embryos to increase the chance of pregnancy and live birth rate is a common practice among assisted reproduction providers but often results in a high proportion of multiple pregnancies. Identifying factors predictive of multiple pregnancies is of paramount importance for the successful development of strategies to minimize multiple gestations. Anti-Müllerian hormone (AMH) has been shown to be closely correlated with a woman’s egg reserve. Aside from the strong association of serum AMH concentration with quantitative ovarian response, serum AMH concentration has been associated with qualitative aspects of assisted reproduction such as embryo quality and pregnancy rates. Our objective was to evaluate AMH as a possible predictor of twin pregnancy in women undergoing fresh cycles who had more than one embryo transferred. Our study included 139 patients undergoing fresh non-donor cycles which resulted in either a singleton or twin pregnancy between 2009 and 2010 in our fertility clinic. Random serum AMH concentrations were compared. For further analysis, the population was divided into two groups (age &lt;34 and ⩾34). AMH concentrations were 1.4-times greater in women conceiving twins compared with singletons. In women aged ⩾34, the AMH concentration in twins was 1.8-fold greater than singleton pregnancies. AMH was an independent predictor of twins with a significant predictive ability for twin pregnancy in women aged ⩾34. In contrast, in women aged &lt;34, AMH was not different between twin and singleton pregnancies. In conclusion, considering a woman’s AMH before transferring more than one embryo may assist in reducing the incidence of twins.</description><identifier>ISSN: 1472-6483</identifier><identifier>EISSN: 1472-6491</identifier><identifier>DOI: 10.1016/j.rbmo.2012.12.002</identifier><identifier>PMID: 23419793</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Age Factors ; Anti-Mullerian Hormone - blood ; anti-Müllerian hormone ; assisted reproduction technology ; Biomarkers - blood ; Embryo Transfer ; Female ; Humans ; Multivariate Analysis ; Obstetrics and Gynecology ; Predictive Value of Tests ; Pregnancy ; Pregnancy, Multiple - blood ; Retrospective Studies ; single-embryo transfer ; twin pregnancy</subject><ispartof>Reproductive biomedicine online, 2013-04, Vol.26 (4), p.360-367</ispartof><rights>Reproductive Healthcare Ltd.</rights><rights>2012 Reproductive Healthcare Ltd.</rights><rights>Copyright © 2012 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-d1b4153db180a67776bca01d5fd7aa727bd0ee78a24f4a4132ced9c2cfcdebb93</citedby><cites>FETCH-LOGICAL-c455t-d1b4153db180a67776bca01d5fd7aa727bd0ee78a24f4a4132ced9c2cfcdebb93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1472648312007456$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23419793$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tal, Reshef</creatorcontrib><creatorcontrib>Seifer, David B</creatorcontrib><creatorcontrib>Khanimov, Moisey</creatorcontrib><creatorcontrib>Schwartz, Eliana</creatorcontrib><creatorcontrib>Grazi, Richard V</creatorcontrib><creatorcontrib>Malter, Henry E</creatorcontrib><title>Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles</title><title>Reproductive biomedicine online</title><addtitle>Reprod Biomed Online</addtitle><description>Abstract This study evaluated anti-Müllerian hormone (AMH) as a possible predictor of twin pregnancy in women undergoing fresh cycles who had more than one embryo transferred. A retrospective study was performed of 139 patients undergoing fresh non-donor cycles which resulted in either singleton or twin pregnancy between 2009 and 2010 in this fertility clinic. Random serum AMH and other clinically relevant variables were compared. For further analysis, the population was stratified by age (&lt;34 and ⩾34 years). Random serum AMH concentrations were 1.4-times greater in women conceiving twins compared with singletons ( P = 0.03). In women aged ⩾34, the AMH concentration in twins was 1.8-fold greater than singletons ( P = 0.001). Multivariate analysis demonstrated that AMH was an independent predictor of twins. ROC curve analysis showed that AMH had a significant predictive ability for twin pregnancy in women aged ⩾34 (AUC 0.67, P = 0.01). In contrast, in women aged &lt;34, AMH was not different between twin and singleton pregnancies. In summary, random serum AMH is an independent predictor of twin gestation when more than one embryo is transferred in women aged ⩾34. Considering a woman’s AMH before transferring more than one embryo may assist in reducing the incidence of twins. Transferring multiple embryos to increase the chance of pregnancy and live birth rate is a common practice among assisted reproduction providers but often results in a high proportion of multiple pregnancies. Identifying factors predictive of multiple pregnancies is of paramount importance for the successful development of strategies to minimize multiple gestations. Anti-Müllerian hormone (AMH) has been shown to be closely correlated with a woman’s egg reserve. Aside from the strong association of serum AMH concentration with quantitative ovarian response, serum AMH concentration has been associated with qualitative aspects of assisted reproduction such as embryo quality and pregnancy rates. Our objective was to evaluate AMH as a possible predictor of twin pregnancy in women undergoing fresh cycles who had more than one embryo transferred. Our study included 139 patients undergoing fresh non-donor cycles which resulted in either a singleton or twin pregnancy between 2009 and 2010 in our fertility clinic. Random serum AMH concentrations were compared. For further analysis, the population was divided into two groups (age &lt;34 and ⩾34). AMH concentrations were 1.4-times greater in women conceiving twins compared with singletons. In women aged ⩾34, the AMH concentration in twins was 1.8-fold greater than singleton pregnancies. AMH was an independent predictor of twins with a significant predictive ability for twin pregnancy in women aged ⩾34. In contrast, in women aged &lt;34, AMH was not different between twin and singleton pregnancies. In conclusion, considering a woman’s AMH before transferring more than one embryo may assist in reducing the incidence of twins.</description><subject>Age Factors</subject><subject>Anti-Mullerian Hormone - blood</subject><subject>anti-Müllerian hormone</subject><subject>assisted reproduction technology</subject><subject>Biomarkers - blood</subject><subject>Embryo Transfer</subject><subject>Female</subject><subject>Humans</subject><subject>Multivariate Analysis</subject><subject>Obstetrics and Gynecology</subject><subject>Predictive Value of Tests</subject><subject>Pregnancy</subject><subject>Pregnancy, Multiple - blood</subject><subject>Retrospective Studies</subject><subject>single-embryo transfer</subject><subject>twin pregnancy</subject><issn>1472-6483</issn><issn>1472-6491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc-KFDEQxoMo7h99AQ-So5ceU0m6Mw0iLIuuwooH9RzSSfVuxnQyJt0r827efDHTzLoHD0KRVOD7fVS-IuQFsA0w6F7vNnmY0oYz4JtajPFH5BSk4k0ne3j80G_FCTkrZccYbNlWPCUnXEjoVS9OyXgRZ998-v0rBMzeRHqb8pQiUlNoffnocI_1iDPdZ3TezinTNNL5p4_0DnNZCi0-3gScU1wlN9FEe6ggHTOWW2oPNmB5Rp6MJhR8fn-fk2_v3329_NBcf776eHlx3VjZtnPjYJDQCjfUQU2nlOoGaxi4dnTKGMXV4Bii2houR2kkCG7R9Zbb0Tochl6ck1dH331OPxYss558sRiCiZiWoishRc-ghyrlR6nNqZSMo95nP5l80MD0mq_e6TVfveara9V8K_Ty3n8ZJnQPyN9Aq-DNUYD1l3cesy7WY6xj-ox21i75__u__Qe3wUdvTfiOByy7tORY89OgSwX0l3XD64KBM6Zk24k_LYaj_Q</recordid><startdate>20130401</startdate><enddate>20130401</enddate><creator>Tal, Reshef</creator><creator>Seifer, David B</creator><creator>Khanimov, Moisey</creator><creator>Schwartz, Eliana</creator><creator>Grazi, Richard V</creator><creator>Malter, Henry E</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130401</creationdate><title>Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles</title><author>Tal, Reshef ; Seifer, David B ; Khanimov, Moisey ; Schwartz, Eliana ; Grazi, Richard V ; Malter, Henry E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-d1b4153db180a67776bca01d5fd7aa727bd0ee78a24f4a4132ced9c2cfcdebb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Age Factors</topic><topic>Anti-Mullerian Hormone - blood</topic><topic>anti-Müllerian hormone</topic><topic>assisted reproduction technology</topic><topic>Biomarkers - blood</topic><topic>Embryo Transfer</topic><topic>Female</topic><topic>Humans</topic><topic>Multivariate Analysis</topic><topic>Obstetrics and Gynecology</topic><topic>Predictive Value of Tests</topic><topic>Pregnancy</topic><topic>Pregnancy, Multiple - blood</topic><topic>Retrospective Studies</topic><topic>single-embryo transfer</topic><topic>twin pregnancy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tal, Reshef</creatorcontrib><creatorcontrib>Seifer, David B</creatorcontrib><creatorcontrib>Khanimov, Moisey</creatorcontrib><creatorcontrib>Schwartz, Eliana</creatorcontrib><creatorcontrib>Grazi, Richard V</creatorcontrib><creatorcontrib>Malter, Henry E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Reproductive biomedicine online</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tal, Reshef</au><au>Seifer, David B</au><au>Khanimov, Moisey</au><au>Schwartz, Eliana</au><au>Grazi, Richard V</au><au>Malter, Henry E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles</atitle><jtitle>Reproductive biomedicine online</jtitle><addtitle>Reprod Biomed Online</addtitle><date>2013-04-01</date><risdate>2013</risdate><volume>26</volume><issue>4</issue><spage>360</spage><epage>367</epage><pages>360-367</pages><issn>1472-6483</issn><eissn>1472-6491</eissn><abstract>Abstract This study evaluated anti-Müllerian hormone (AMH) as a possible predictor of twin pregnancy in women undergoing fresh cycles who had more than one embryo transferred. A retrospective study was performed of 139 patients undergoing fresh non-donor cycles which resulted in either singleton or twin pregnancy between 2009 and 2010 in this fertility clinic. Random serum AMH and other clinically relevant variables were compared. For further analysis, the population was stratified by age (&lt;34 and ⩾34 years). Random serum AMH concentrations were 1.4-times greater in women conceiving twins compared with singletons ( P = 0.03). In women aged ⩾34, the AMH concentration in twins was 1.8-fold greater than singletons ( P = 0.001). Multivariate analysis demonstrated that AMH was an independent predictor of twins. ROC curve analysis showed that AMH had a significant predictive ability for twin pregnancy in women aged ⩾34 (AUC 0.67, P = 0.01). In contrast, in women aged &lt;34, AMH was not different between twin and singleton pregnancies. In summary, random serum AMH is an independent predictor of twin gestation when more than one embryo is transferred in women aged ⩾34. Considering a woman’s AMH before transferring more than one embryo may assist in reducing the incidence of twins. Transferring multiple embryos to increase the chance of pregnancy and live birth rate is a common practice among assisted reproduction providers but often results in a high proportion of multiple pregnancies. Identifying factors predictive of multiple pregnancies is of paramount importance for the successful development of strategies to minimize multiple gestations. Anti-Müllerian hormone (AMH) has been shown to be closely correlated with a woman’s egg reserve. Aside from the strong association of serum AMH concentration with quantitative ovarian response, serum AMH concentration has been associated with qualitative aspects of assisted reproduction such as embryo quality and pregnancy rates. Our objective was to evaluate AMH as a possible predictor of twin pregnancy in women undergoing fresh cycles who had more than one embryo transferred. Our study included 139 patients undergoing fresh non-donor cycles which resulted in either a singleton or twin pregnancy between 2009 and 2010 in our fertility clinic. Random serum AMH concentrations were compared. For further analysis, the population was divided into two groups (age &lt;34 and ⩾34). AMH concentrations were 1.4-times greater in women conceiving twins compared with singletons. In women aged ⩾34, the AMH concentration in twins was 1.8-fold greater than singleton pregnancies. AMH was an independent predictor of twins with a significant predictive ability for twin pregnancy in women aged ⩾34. In contrast, in women aged &lt;34, AMH was not different between twin and singleton pregnancies. In conclusion, considering a woman’s AMH before transferring more than one embryo may assist in reducing the incidence of twins.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>23419793</pmid><doi>10.1016/j.rbmo.2012.12.002</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1472-6483
ispartof Reproductive biomedicine online, 2013-04, Vol.26 (4), p.360-367
issn 1472-6483
1472-6491
language eng
recordid cdi_proquest_miscellaneous_1324390191
source MEDLINE; Elsevier ScienceDirect Journals
subjects Age Factors
Anti-Mullerian Hormone - blood
anti-Müllerian hormone
assisted reproduction technology
Biomarkers - blood
Embryo Transfer
Female
Humans
Multivariate Analysis
Obstetrics and Gynecology
Predictive Value of Tests
Pregnancy
Pregnancy, Multiple - blood
Retrospective Studies
single-embryo transfer
twin pregnancy
title Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T01%3A52%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-M%C3%BCllerian%20hormone%20as%20an%20independent%20predictor%20of%20twin%20versus%20singleton%20pregnancy%20in%20fresh%20cycles&rft.jtitle=Reproductive%20biomedicine%20online&rft.au=Tal,%20Reshef&rft.date=2013-04-01&rft.volume=26&rft.issue=4&rft.spage=360&rft.epage=367&rft.pages=360-367&rft.issn=1472-6483&rft.eissn=1472-6491&rft_id=info:doi/10.1016/j.rbmo.2012.12.002&rft_dat=%3Cproquest_cross%3E1324390191%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1324390191&rft_id=info:pmid/23419793&rft_els_id=1_s2_0_S1472648312007456&rfr_iscdi=true